In 2012, Dieterich et al. identified 95 genes differentially expressed in glioblastoma blood vessels, highlighting increased CD93 gene and protein expression, which correlated with tumor grade, reaching its highest in grade IV gliomas [179]. This evidence concerns the gene CD93 and central nervous system cancer.